7B2 knockout transgenic animals as models of endocrine disease
US7348156B2 · kind B2 · utility
1Cited by
6References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 3, 2003 |
| Grant date | Mar 25, 2008 |
| Priority date | — |
| Expiry date | May 15, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0362
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
In general, the invention features methods and uses for transposon-mediated gene targeting which greatly enhance the insertion and detection of desired genes in genomic exons by homologous recombination. The invention also features transgenic non-human mammals, and eukaryotic cells, wherein a gene encoding 7B2 protein is modified, as well as nucleic acid vectors capable of undergoing homologous recombination with an endogenous 7B2 gene in a cell. The invention also features transgenic non-human mammals as models of endocrine disorders, as well as methods for diagnosing and treating patients with endocrine disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.